About Northeast Georgia Heart Center, Gainesville, Georgia, USANortheast Georgia Heart Center (NGHS) is the state's leader in cardiac care. The physicians at The Heart Center are consistently recognized as some of the top cardiovascular physicians in the country. It is through their leadership and collaboration that Northeast Georgia Medical Center has been recognized as the #1 heart hospital in the State of Georgia for the last seven years running, according to HealthGrades © nationally recognized organization to rank healthcare facilities based on outcomes for a variety of diagnoses and procedures. Our cardiologists have the experience that leads to expertise. We perform more than 5,000 cardiac procedures and consult more than 30,000 patients each year. Patients and families can trust the unsurpassed experience the physicians at The Heart Center provide. Our physicians remain on the forefront of prevention and disease management by our participation in clinical research and trials. We contribute at a global level to the advancement of cardiovascular treatments. For more information on NGHS please go to: www.nghs.com
About Kips Bay MedicalKips Bay Medical, Inc., founded in 2007 and headquartered in Minneapolis, Minnesota, is a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, or eSVS MESH, for use in coronary artery bypass grafting surgery. The eSVS MESH is a nitinol mesh sleeve that, when placed on the outside of a saphenous vein graft during CABG surgery, is designed to improve the structural characteristics and long-term performance of the saphenous vein graft. Additional information about Kips Bay Medical, Inc. can be found at www.KipsBayMedical.com.
Safe HarborCertain statements in this news release are
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995 and are provided under the protection of
the safe harbor for forward-looking statements provided by that Act.
Statements in this release regarding the eSVS Mesh as a tool to improve
clinical outcomes and the use of the data from this study as the basis
for filing a request for an investigational device exemption to perform
a pivotal trial in the U.S. are examples of forward-looking statements.
These forward-looking statements involve risks and uncertainties which
could cause results to differ materially from those projected, including
but not limited to the risks detailed from time to time in Kips Bay
Medical’s SEC reports, including its most recent annual report on Form
10-K and subsequent quarterly reports on Form 10-Q. Kips Bay Medical
encourages you to consider all of these risks, uncertainties and other
factors carefully in evaluating the forward-looking statements contained
in this release.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV